Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Influenza A virus vaccine H7N9 - Sanofi

Next Previous
Search
Drug Profile

Influenza A virus vaccine H7N9 - Sanofi

Alternative Names: 2017 H7N9 IIV; A/H7N9 virus vaccine

Latest Information Update: 04 Apr 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator sanofi pasteur
  • Developer National Institute of Allergy and Infectious Diseases; Sanofi Pasteur
  • Class Influenza A vaccines; Influenza A virus H7N9 vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Influenza A virus H7N9 subtype

Most Recent Events

  • 27 Jan 2022 No development reported - Phase-II for Influenza A virus H7N9 subtype (In the elderly, Prevention, In adults) in USA (IM), before January 2022 (sanofi pasteur pipeline, January 2022)
  • 04 Mar 2021 No development reported - Phase-II for Influenza A virus H7N9 subtype (Prevention, Adjuvant therapy) in USA (IM), before March (sanofi pasteur pipeline, March 2021).
  • 12 Nov 2018 National Institute of Allergy and Infectious diseases plans a phase II trial for Influenza (Prevention, In adults, In the elderly) in USA in December 2018 (NCT03738241)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top